Top Markets
Coin of the day
Parenteral Drugs (India) Ltd. Parenteral Drugs (India) Ltd.

Parenteral Drugs (India) Ltd.

PDPL
Rank in Stocks #38236
Parenteral Drugs (India) Limited operates as an India-based healthcare... Parenteral Drugs (India) Limited operates as an India-based healthcare enterprise, specializing in the production of a diverse range of pharmaceutical goods. Its offerings encompass various medicinal products, including intravenous and inhalation therapies, as well as veterinary infusions. The company's extensive product portfolio further comprises various intravenous (IV) solutions, such as those containing carbohydrates and electrolytes, diuretics, and solutions for dialysis and irrigation. Additionally, they provide anti-infective, anti-fungal, oncology, and anesthesia medications. The firm maintains a significant international presence, exporting its goods to numerous nations including Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. Established in 1983, Parenteral Drugs (India) Limited's operations are headquartered in Indore, India.
Share Price
$0.03200404
Last synced: 2024-07-23
Market Cap
$1.12M
Change (1 day)
-8.12%
Change (1 year)
0.00%
Country
IN
Trade Parenteral Drugs (India) Ltd. (PDPL)

Category

P/E ratio for Parenteral Drugs (India) Ltd. (PDPL)
P/E ratio as of 2026 TTM: 0
According to Parenteral Drugs (India) Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Parenteral Drugs (India) Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.